VONISH-M 0.2TABLET

Product Description

Product Name: VONISH-M 0.2 Tablet
Composition: Voglibose (0.2mg) + Metformin (500mg) (Bi-Layered Formulation)
Packaging: Blister Pack | GMP Certified | Prescription-Based

Product Overview:
VONISH-M 0.2 Tablet is a powerful anti-diabetic combination therapy designed for effective management of Type 2 Diabetes Mellitus. This bi-layered formulation synergizes Voglibose and Metformin to deliver enhanced glycemic control by targeting both postprandial and fasting blood glucose levels.

Key Benefits:

• Dual-action control on blood sugar: postprandial & basal

• Voglibose slows carbohydrate absorption, reducing sugar spikes

• Metformin improves insulin sensitivity & reduces hepatic glucose output

• Bi-layered design ensures optimal release profile

• Trusted by diabetologists and general practitioners

Usage & Indication:
Indicated as an adjunct to diet and exercise for adults with Type 2 Diabetes not adequately controlled with Metformin monotherapy. Dosage as directed by a healthcare professional.

Ideal For:

• Bulk pharmaceutical distributors

• Generic medicine exporters

• Retail pharmacy chains

• Hospital procurement managers

• PCD franchise companies